New Horizon Wellness Clinic

New Horizon Wellness Clinic operates as a telehealth-focused practice serving patients throughout Florida, with administrative headquarters in Jacksonville Beach. The clinic concentrates exclusively on metabolic health interventions, specifically utilizing GLP-1 receptor agonist peptides for weight management and glycemic control in patients with obesity and type 2 diabetes. Medical director Dr. Patricia Hernandez, a board-certified family medicine physician with additional certification in obesity medicine, leads the clinical team alongside nurse practitioner Michael Chen, who holds specialized training in endocrinology and metabolic disorders. The practice model eliminates geographic barriers for Florida residents seeking peptide-based weight loss therapy, allowing patients from Miami to Pensacola to access specialized metabolic care without traveling to Jacksonville Beach.

The clinic's treatment protocols center on two specific peptide medications: semaglutide and tirzepatide. Semaglutide, marketed under various brand names, functions as a GLP-1 receptor agonist that regulates appetite signals and slows gastric emptying, while tirzepatide operates through dual GIP/GLP-1 receptor agonism for enhanced metabolic effects. New Horizon Wellness prescribes these peptides following comprehensive metabolic assessments that include fasting glucose, hemoglobin A1c, lipid panels, thyroid function tests, and kidney function markers. Dosing follows evidence-based titration schedules, typically starting semaglutide at 0.25 mg weekly with gradual increases to therapeutic levels between 1.0-2.4 mg weekly, or tirzepatide beginning at 2.5 mg weekly with potential escalation to 15 mg weekly based on individual response and tolerance. The clinic sources peptides exclusively from FDA-registered compounding pharmacies or dispenses brand-name formulations depending on insurance coverage and patient preference. Patients receive detailed injection technique training during initial video consultations, with the clinic providing sharps disposal guidance and injection site rotation protocols to minimize adverse reactions.

Dr. Hernandez completed her obesity medicine fellowship at the University of Florida College of Medicine in Gainesville and maintains active membership in the Obesity Medicine Association. Her clinical approach integrates peptide therapy with behavioral modification strategies, requiring patients to complete food logging through designated mobile applications and participate in biweekly accountability check-ins during the initial three months of treatment. Nurse practitioner Chen conducts monthly medication management appointments via secure video platform, adjusting peptide dosages based on weight loss velocity, side effect profiles, and laboratory monitoring results. The practice does not prescribe peptides as standalone interventions; all patients must engage with the clinic's structured nutrition education modules covering macronutrient distribution, meal timing strategies, and sustainable eating patterns that support long-term weight maintenance after peptide therapy concludes. For patients with type 2 diabetes, the clinic coordinates care with existing endocrinologists, providing detailed treatment summaries and requesting A1c results every 90 days to assess glycemic improvement alongside weight reduction.

New patients complete an online intake form documenting medical history, current medications, previous weight loss attempts, and metabolic health markers before scheduling their initial telehealth consultation. The first appointment, typically lasting 45-60 minutes, includes review of recent laboratory work (patients must obtain labs within 30 days of consultation), discussion of realistic weight loss expectations, and education about common peptide side effects including nausea, constipation, and injection site reactions. Dr. Hernandez or Chen determine peptide candidacy based on BMI thresholds (typically 30 or above, or 27 with obesity-related comorbidities), absence of contraindications such as personal or family history of medullary thyroid carcinoma, and patient commitment to the clinic's monitoring requirements. Patients approved for treatment receive electronic prescriptions sent directly to their preferred pharmacy, with the first peptide shipment typically arriving within 5-7 business days. Follow-up appointments occur at two-week intervals initially, then monthly once stable dosing is achieved. The clinic requires patients to submit weight measurements and side effect reports through the patient portal between scheduled appointments, allowing providers to identify concerning trends or adverse reactions requiring dosage modification.

New Horizon Wellness Clinic differentiates itself through transparent pricing structures published on its website, with consultation fees, monthly medication management costs, and estimated peptide expenses clearly itemized for Florida patients evaluating treatment affordability. The practice accepts select insurance plans for medical consultations but notes that peptide coverage varies significantly by carrier and policy type, with many patients paying out-of-pocket for medications. For patients whose insurance denies coverage, the clinic maintains relationships with compounding pharmacies offering competitive pricing on semaglutide and tirzepatide formulations. The telehealth delivery model eliminates travel time and allows patients to schedule appointments during lunch breaks or after traditional office hours, with availability extending to early evening slots throughout the week. All video consultations occur through HIPAA-compliant platforms requiring no special software downloads, accessible via smartphone, tablet, or computer. The clinic's Florida-exclusive licensure means providers maintain deep familiarity with the state's insurance landscape, prior authorization processes, and pharmacy networks, streamlining medication access for Jacksonville Beach area residents and patients throughout the state's 67 counties.